Physician profile
Michael D Sheehan
NPI 1972534170
$2,726.70
in general payments reported to CMS, 2019-2025
23 companies · $51.56 in 2025
The $51.56 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,152 · 2020: $286 · 2021: $300 · 2022: $145 · 2023: $704 · 2024: $88.03 · 2025: $51.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $533.92 | 2019-2023 | |
| Novo Nordisk INC | $519.40 | 2019-2023 | Ozempic, Rybelsus |
| Abbvie INC. | $467.60 | 2023-2024 | Vraylar |
| Sanofi-Aventis U.S. LLC | $194.10 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $154.52 | 2019-2023 | Xifaxan |
| Glaxosmithkline, LLC. | $111.00 | 2019-2020 | |
| Lilly USA, LLC | $100.24 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $94.75 | 2019-2020 | |
| Abbott Laboratories | $90.06 | 2021-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.92 | 2019-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $76.65 | 2019-2020 | |
| Amgen INC. | $70.27 | 2019-2021 | |
| Allergan, INC. | $39.71 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $36.10 | 2021 | |
| Exact Sciences Corporation | $27.71 | 2025 | Cologuard Collection Kit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $18.22 | 2019 | |
| Dexcom, INC. | $17.88 | 2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $16.63 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $16.55 | 2019 | |
| Corium, LLC | $15.39 | 2023 | Adlarity |
| Sanofi Pasteur INC. | $14.10 | 2019 | |
| Scilex Pharmaceuticals INC. | $11.81 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sheehan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.